Upcoming Clinical Trial: SNORE-AF

Sleep Apnoea and Atrial Fibrillation: treatment of sleep apnoea, effects on ablation outcomes (SNORE-AF)

The number of patients recruited by Canberra Heart Rhythm: not enrolling yet

SYNOPSIS OF THE STUDY:

  • The study aims to investigate the impact of Obstructive Sleep Apnoea treatment on Atrial Fibrillation utilising a randomised controlled trial design.
  • Hypothesis: treatment of sleep apnoea will reduce the burden/recurrence of atrial fibrillation.
  • Primary endpoint: time to AF recurrence following AF ablation at 12 month
  • Secondary endpoint: single procedure freedom from AF recurrence at 24 months, multi-procedure AF recurrence at 12 and 24 months and reduction of AF burden

 

INCLUSION CRITERIA:

  • Has atrial fibrillation
  • Moderate to servere obstructive sleep apnoea as AHI > or = 15
  • Over 18yrs olf
  • Able and willing to provide informed consent and comply with all the testing and requirements

 

EXCLUSION CRITERIA:

  • Has valvular heart disease
  • Has AF due to trasient or reversible cause ie. post operative cardiac or non-cardiac surgery lung disease, hyperthyroidism

 

Picture1